Johnson & Johnson Struggling


anonymous

Guest
J&J is now struggling and Kenvue is thriving. Hiring freezes, travel bans, project cancellations, budget cuts, layoffs, and management decisions will now be the norm for J&J. Regular base activities are being impacted severely. Even DE&I initiatives have been scaled back severely. If the stockholders knew that the legacy J&J was in crisis, they would and should sell sell sell, now.

200 people were laid off in Cincinnati. 800 people were laid off in Leiden. Other J&J sites had smaller layoffs to avoid WARN notices.

Time to jump from the Titanic before the CREDO “music” stops playing.
 




Too early to tell on Kenvue..but I do agree on JNJ struggles. Layoffs and layoffs but yet to upside. At this rate..will Medtech be the next spin-off?

A huge chunk of medtech has already been spun-off. Goodbye to Cordis, LifeScan, Animas, ASP, Codman, OCD, & Calibra, plus the Synthes divestiture to Jabil.

The rest of Orthopedics, Mentor, & Acclarent are likely next in the garage sale.
 


A huge chunk of medtech has already been spun-off. Goodbye to Cordis, LifeScan, Animas, ASP, Codman, OCD, & Calibra, plus the Synthes divestiture to Jabil.

The rest of Orthopedics, Mentor, & Acclarent are likely next in the garage sale.

Which J&J businesses are most stable and expected to see some growth?

I’m trying to find a role for several months now. I don’t understand why hiring managers are so picky for recruiting talent. I’m a top performer. Internal job search has been very disappointing and demoralizing.

I don’t even see many job postings anymore. Is it better to quit J&J? What are some better companies to join.
 


Which J&J businesses are most stable and expected to see some growth?

I’m trying to find a role for several months now. I don’t understand why hiring managers are so picky for recruiting talent. I’m a top performer. Internal job search has been very disappointing and demoralizing.

I don’t even see many job postings anymore. Is it better to quit J&J? What are some better companies to join.

I would seriously consider Kenvue. Less uncertainty for its product lines. Kenvue's product lines are stable, decades & some even a century old, and they're not going anywhere. At least with Kenvue, you already have a long history with their products & sales trajectory, so there won't be any major surprises.

JNJ Pharma has some major patent cliffs coming up shortly, especially with Stelera, and JNJ Medtech is pretty anaemic outside of BWI.
 


Which J&J businesses are most stable and expected to see some growth?

I’m trying to find a role for several months now. I don’t understand why hiring managers are so picky for recruiting talent. I’m a top performer. Internal job search has been very disappointing and demoralizing.

I don’t even see many job postings anymore. Is it better to quit J&J? What are some better companies to join.

you must be over 30 and white if you are not being interviewed, seriously
 










OP said Kenvue is thriving..lol.
I would say Kenvue is thriving in stability, while JNJ faces uncertainty with talc lawsuits, pharma patent cliffs, & an erratic medtech business with poor execution.

Another point to consider, JNJ gave the rights to the "Johnson's" brand name to Kenvue for free according to the IPO agreement. From a marketing point of view, this is a very telling sign that the new JNJ moving forward has more plans to split itself up, probably by divesting and/or shuttering more of medtech & renaming itself to Janssen when all that's left are pharma products.
 










WATCH! JNJ will sell all of Medtech by 2026 and just leave Pharma. People in Medtech should start looking elsewhere now

I wonder if this strategy will be used to declare bankruptcy for corporate JNJ, while pharma & medtech split into separate legal entities with none of the talc liabilities. Janssen would be an independent pharma company & Ethicon/DePuy Synthes/BWI/Vision would be a separate independent medical device conglomerate company.
 


I wonder if this strategy will be used to declare bankruptcy for corporate JNJ, while pharma & medtech split into separate legal entities with none of the talc liabilities. Janssen would be an independent pharma company & Ethicon/DePuy Synthes/BWI/Vision would be a separate independent medical device conglomerate company.

most brilliant post on here ever, or, leave MedTech with J&J to go bankrupt and break Janssen to a separate, profitable, company.
 









Write your reply...